Skip to main content
Book cover

Prehypertension and Cardiometabolic Syndrome

  • Book
  • © 2019

Overview

  • Provides valuable guidance for identifying which asymptomatic pre-hypertensive subjects could profit from being appropriately screened and treated
  • Fills a knowledge gap and lays the groundwork for developing recommendations and guidelines
  • Will benefit cardiologists, primary care physicians and all those healthcare professional looking to optimally manage these complex and often-undiagnosed cases

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (42 chapters)

  1. Epidemiology and Statistics

  2. Organ Damage in Prehypertension

Keywords

About this book

This book sheds new light on the management of patients with borderline cardiovascular risk factors in order to prevent their progression to end organ damage. The book stimulates discussion of this poorly understood condition and lays the groundwork for developing recommendations and guidelines.

While the diagnostic and therapeutic approach to full-blown diabetes, hypertension, dyslipidemia and obesity is well defined, there is still a lack of clear understanding and guidelines as far as patients with borderline conditions – especially when multiple – are concerned. Moreover, end-organ damage depends on several factors, including genetic factors, making it difficult to predict its extent. As such, the gradual transition from a healthy subject to one with functional hemodynamic changes, and then one with structurally asymptomatic changes and lastly to overt disease needs further investigation.

In order to address these knowledge gaps, the book covers a broad variety of topics, making it a valuable tool for identifying which asymptomatic subjects could profit from being appropriately screened and at what stage. Furthermore it offers insights into better treating these patients to prevent their progression to overt disease. The book appeals to cardiologists, primary care physicians and all those healthcare professional looking to optimize the management of these complex and often undiagnosed cases.

Editors and Affiliations

  • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Reuven Zimlichman

  • Department of Internal Medicine, University of Michigan, Ann Arbor, USA

    Stevo Julius

  • Emeritus Professor of Medicine, University of Milano-Bicocca, Milan, Italy

    Giuseppe Mancia

About the editors

Reuven Zimlichman is Chief of the Department of Medicine, Head of the Hypertension Institute at the E. Wolfson Medical Center, Israel, Director of ‘The Brunner Cardiovascular Research Institute’, Tel-Aviv University and Director of the 'Institute for Quality in Medicine', Israeli Medical Association. He is also a former Vice Dean and Head of School of the Continuing Education program at the Sackler Faculty of Medicine, Tel Aviv University. Zimlichman has published more than 200 papers, 5 books and numerous book chapters. His publications are in the fields of basic research, cell cultures, animal research and clinical research and cover clinical areas including hypertension, cardiovascular disease, metabolic syndrome, end organ damage and evaluation of arterial properties.

Stevo Julius, Professor Emeritus at the University of Michigan Cardiovascular Center, is one of the early pioneers in the field of hypertension whose work has focused on not only treating hypertension, but on preventing it. He has over the years addressed major questions concerning the relation of sympathetic activity and heart rate to hypertension and its complications. He has led or participated in the most innovative therapeutic trials and also distinguished himself as an educator, training two generations of teachers and researchers. He has led the International Society of Hypertension  and other clinical societies. Julius is the author of over 300 papers and book chapters and is Member of the Editorial Board on a number of journals on Hypertension.

Giuseppe Mancia is a Professor Emeritus of the University of Milano-Bicocca and served as Professor of Medicine and Head of the First Division of Medicine at the San Gerardo Hospital, Italy. He is executive officer of the European Society of Hypertension and Chair of the ESH Educational Committee. Mancia’s research interests are focused on the pathophysiology, diagnosis and therapy of hypertension, heart failure, coronary and other cardiovascular diseases. His fields of expertise include ambulatory blood pressure monitoring, neural control of circulation, large artery mechanics, and clinical trials.

Bibliographic Information

  • Book Title: Prehypertension and Cardiometabolic Syndrome

  • Editors: Reuven Zimlichman, Stevo Julius, Giuseppe Mancia

  • Series Title: Updates in Hypertension and Cardiovascular Protection

  • DOI: https://doi.org/10.1007/978-3-319-75310-2

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing AG, part of Springer Nature 2019

  • Hardcover ISBN: 978-3-319-75309-6Published: 20 December 2018

  • eBook ISBN: 978-3-319-75310-2Published: 06 December 2018

  • Series ISSN: 2366-4606

  • Series E-ISSN: 2366-4614

  • Edition Number: 1

  • Number of Pages: XII, 689

  • Number of Illustrations: 39 b/w illustrations, 72 illustrations in colour

  • Topics: Cardiology, Angiology, Diabetes, Metabolic Diseases, Primary Care Medicine

Publish with us